Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 162.18B | 165.34B | 155.63B | 148.19B | 137.61B | 134.69B |
Gross Profit | 17.12B | 17.44B | 16.43B | 15.77B | 14.53B | 14.33B |
EBITDA | 4.67B | 4.80B | 4.92B | 4.31B | 4.11B | 3.76B |
Net Income | 2.73B | 2.89B | 2.61B | 2.57B | 2.41B | 2.23B |
Balance Sheet | ||||||
Total Assets | 109.13B | 85.50B | 80.00B | 72.01B | 64.42B | 63.21B |
Cash, Cash Equivalents and Short-Term Investments | 7.23B | 5.11B | 5.50B | 3.40B | 3.31B | 4.18B |
Total Debt | 36.04B | 15.02B | 9.39B | 9.54B | 8.15B | 9.04B |
Total Liabilities | 76.36B | 53.18B | 48.78B | 43.83B | 38.49B | 38.86B |
Stockholders Equity | 32.77B | 32.32B | 31.22B | 28.16B | 25.92B | 24.33B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -4.43B | 2.45B | 1.44B | -179.00M | -2.94B |
Operating Cash Flow | 0.00 | 2.47B | 3.68B | 2.29B | 1.94B | -939.00M |
Investing Cash Flow | 0.00 | -7.27B | -316.00M | -2.80B | -710.00M | -1.67B |
Financing Cash Flow | 0.00 | 4.11B | -1.31B | 618.00M | -1.57B | 2.78B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥26.81B | 8.25 | 6.50% | 3.16% | -3.36% | ||
76 Outperform | ¥25.44B | 10.76 | 3.44% | 0.81% | 30.59% | ||
75 Outperform | ¥26.10B | 8.88 | 5.17% | 5.70% | 13.42% | ||
74 Outperform | ¥26.64B | 8.80 | 3.71% | 6.24% | 13.05% | ||
67 Neutral | £2.82B | 10.41 | 4.69% | 3.50% | 2.40% | -24.53% | |
49 Neutral | ¥30.75B | 161.03 | ― | -11.92% | ― | ||
49 Neutral | ¥20.10B | 21.76 | 4.44% | -7.42% | -317.17% |